New study tracks Elocta's Long-Term joint protection in hemophilia
NCT ID NCT04293523
First seen Mar 23, 2026 · Last updated May 11, 2026 · Updated 11 times
Summary
This 48-month observational study looks at how well Elocta, a preventive treatment for hemophilia A, protects joints over time. About 427 people with hemophilia A who already use Elocta will be followed to track joint bleeds, target joint issues, and joint damage. The goal is to understand real-world effectiveness in maintaining joint health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AUSL Romagna Centro Emofilia U.O.C., Medicina Trasfusionale Dipartimento Patologia, Clinica Ospedale M. Bufalini
Cesena, Italy
-
Azienda Ospedaliera Città della Salute e della Scienza di Torino Regina Margherita
Torino, Italy
-
Charité-Universitätsmedizin Berlin Campus Virchow Klinikum
Berlin, Germany
-
Complejo Hospitalario de Navarra
Navarro, Spain
-
Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital Malmö
Malmö, Sweden
-
Dept. of Pediatric Haematology and Oncology, University Hospital Motol
Prague, Czechia
-
Dr Suliman Al Habib Hospital Riyadh
Riyadh, Saudi Arabia
-
East Kent Hospitals University NHS Foundation Trust, Kent Haemophilia and Thrombosis Centre, Kent and Canterbury Hospital
Canterbury, United Kingdom
-
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
-
Giannina Gaslini Institute
Genova, Italy
-
Great Ormond Street Hospital, Royal London Hospital for Integrated Medicine
London, United Kingdom
-
HZRM Hämöphilie Zentrum Rhein Main
Mörfelden-Walldorf, Germany
-
Helsinki University Central Hospital, New Children Hospital
Helsinki, Finland
-
Hematologimottagning Sahlgrenska
Gothenburg, Sweden
-
Hospital Alvaro Cunqueiro
Vigo, Spain
-
Hospital Universitario Carlos Haya
Málaga, Spain
-
Hospital Universitario Central de Asturias (HUCA)
Oviedo, Spain
-
Hospital Universitario Cruces
Cruces, Spain
-
Hospital Universitario Donostia
Donostia / San Sebastian, Spain
-
Hospital Universitario Son Espases
Palma de Mallorca, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Spain
-
Hospital Vall d'Hebron
Barcelona, Spain
-
Hospital Virgen de la Arrixaca
Murcia, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
-
Hämostaseologie/Hämophiliezentrum, Medizinische Klinik 2 Institut für Transfusionsmedizin, Universitätsklinikum
Frankfurt, Germany
-
Ippokrateio Hospital Thessaloniki (adult department)
Thessaloniki, Greece
-
Ippokrateio Hospital Thessaloniki (pediatric department)
Thessaloniki, Greece
-
Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital am Universitätsklinikum München
München, Germany
-
King Faisal Specialised Hospital, KFSH Riyadh, Children
Riyadh, Saudi Arabia
-
King Faisal Specialist Hospital KFSH, Adults
Riyadh, Saudi Arabia
-
Lastehaigla, Tallinn (Tallinn Children´s Hospital)
Tallinn, Estonia
-
Medizinische Hochschule Hannover
Hanover, Germany
-
Riyadh Military Hospital (P.S.M.C)
Riyadh, Saudi Arabia
-
SRH-Klinikum Heidelberg
Heidelberg, Germany
-
Sant Johan De Deu
Barcelona, Spain
-
Service et Laboratoire central d'hématologie, Adults
Lausanne, Switzerland
-
The North Estonia Medical Centre Hematoloogiakeskus, Regionalhaigla
Tallinn, Estonia
-
The Royal Hospital
Muscat, Oman
-
Turku University Central Hospital, Paediatric and adolescent haematology and oncology clinic
Turku, Finland
-
University Hospital Brno
Brno, Czechia
-
University Hospital Ostrava
Ostrava, Czechia
-
University Hospital of Parma, AOUP, Haemophilia Center
Parma, Italy
-
University Medical Center Groningen/UMCG
Groningen, Netherlands
-
University Medical Centre Ljubljana Division of Paediatrics
Ljubljana, Slovenia
-
University of Bari Aldo Moro (Centro Emofilia Policlinico - Pediatria U.O.)
Bari, Italy
-
Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor Inselspital
Bern, Switzerland
-
Universitätsklinikum Bonn AöR, Institut für Experimentelle Hämatologie und Transfusionsmedizin
Bonn, Germany
-
Universitätsklinikum Frankfurt - Klinik für Kinder- und Jugendmedizin
Frankfurt, Germany
-
Universitätsklinikum Hamburg-Eppendorf (UKE)
Hamburg, Germany
-
Universitätsspital Zürich Klinik für Medizinische Onkologie und Hämatologie
Zurich, Switzerland
-
Uo Malattie Emorragiche e Trombotiche Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universitá Catolica del Sacro Coure
Rome, Italy
-
Werlhof-Institut für Hämostaseologie GmbH
Hanover, Germany
-
Zentrum für Labormedizin
Sankt Gallen, Switzerland
Conditions
Explore the condition pages connected to this study.